← Eichor
Study identifier: NCT07424885 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

BeFlared Versus VBX for FEVAR

Condition: Fenestrated Endovascular Aortic Repair  ·  Sponsor: Medical University of Vienna

PhaseNA
Planned participants126
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This randomized controlled unblinded trial aimes to compare BeFlared FEVAR Stent Graft System (BeFlared) with GORE® VIABAHN® VBX Balloon Expandable Endoprothesis (VBX) in patients undergoing endovascular aneurysm repair with fenestrated device (FEVAR). Primary objectives: * compare cumulative device time between patients undergoing FEVAR with BeFlared and VBX brindging device; * compare target vessel (TV) instability at early, short-term and midterm follow-up in patients undergoing FEVAR with BeFlared and VBX brindging device. Secondary objectives: \- compare intraoperative TV technical success in patients undergoing FEVAR with BeFlared and VBX bridging device.

This description comes directly from the study's public registry record.

Talk to the study team

Wolf Hans Eilenberg, MD, PhD  ·  +43 (0)1 40400-69560  ·  wolf.eilenberg@meduniwien.ac.at

Anna Sotir, MD  ·  anna.sotir@meduniwien.ac.at

Always discuss trial participation with your own doctor first.

Locations (1)

Medical University of Vienna, Department of General Surgery, Division of Vascular SurgeryVienna, State of Vienna, AustriaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07424885